Single oligoarray-based detection of specific M918T mutation in RET oncogene in multiple endocrine neoplasia type 2B

被引:0
|
作者
Pacheco-Rivera, R. A. [2 ,7 ]
Hernandez-Zamora, E. [1 ]
Gonzalez-Yebra, B. [3 ]
Beattie, K. [4 ]
Maldonado-Rodriguez, R. [5 ]
Santiago-Hernandez, J. C. [5 ]
Medrano-Ortiz de Zarate, M. E. [6 ]
Salcedo, M. [7 ]
机构
[1] Inst Nacl Rehabil, Serv Genet, Mexico City, DF, Mexico
[2] ENCB IPN, Lab Diagnost Mol, Mexico City, DF, Mexico
[3] Univ Guanajuato, Dept Biol Mol, Guanajuato, Mexico
[4] Oak Ridge Natl Lab, Div Life Sci, Oak Ridge, TN USA
[5] ENCB IPN, Lab Biotecnol & Bioinformat Mol, Mexico City, DF, Mexico
[6] Hosp Oncol, CMN SXXI IMSS, Serv Endocrinol, Mexico City, DF, Mexico
[7] IMSS, UIMEO CMN SXXI, Lab Oncol Genom, Mexico City, DF, Mexico
关键词
Oligoarray; Mutation; MEN; 2B; RET; MEDULLARY-THYROID CARCINOMA; DNA MICROARRAYS; CODON; 634; PROTOONCOGENE; DISEASE; CANCER; HYBRIDIZATION; MANAGEMENT; FAMILIES;
D O I
10.1007/s10238-010-0128-z
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The most important mutation associated with Multiple Endocrine Neoplasia type 2B (MEN 2B) is the change of thymine to cytosine in codon 918 of exon 16 in the RET oncogene (ATG -> ACG). The aim of this work was to develop a single oligoarray by using tandem hybridization to detect the T918C/RET mutation for MEN 2B patients. Two genetically non-related families were studied; each family had a member affected by MEN2B. Both patients presented the T918C/RET mutation in a heterozygous fashion. None of the relatives was positive for this mutation; thus, these cases arose de novo. The proper mutation was confirmed by with different tools, PCR-Fok I endonuclease, direct sequencing, and also using our oligoarray. In this case, it is suitable to use a DNA target smaller than 150 bases with single-or double-stranded DNA and short probes of 7-mer. It was also possible to detect the mutation by employing different sources of DNA, fresh or paraffin-embedded tissues. Therefore, the present oligoarray can identify the most common M918T mutation of RET oncogene from a variety of DNA sources with good specificity and be a good alternative in the molecular diagnosis for MEN 2B cases.
引用
收藏
页码:227 / 234
页数:8
相关论文
共 50 条
  • [21] Multiple endocrine neoplasias type 2B and RET proto-oncogene
    Giuseppe Martucciello
    Margherita Lerone
    Lara Bricco
    Gian Paolo Tonini
    Laura Lombardi
    Carmine G Del Rossi
    Sergio Bernasconi
    Italian Journal of Pediatrics, 38
  • [22] Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation
    Miyauchi, A
    Futami, H
    Hai, N
    Yokozawa, T
    Kuma, K
    Aoki, N
    Kosugi, S
    Sugano, K
    Yamaguchi, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (01): : 1 - 5
  • [23] SINGLE MISSENSE MUTATION IN THE TYROSINE KINASE CATALYTIC DOMAIN OF THE RET PROTOONCOGENE IS ASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B
    CARLSON, KM
    DOU, SS
    CHI, D
    SCAVARDA, N
    TOSHIMA, K
    JACKSON, CE
    WELLS, SA
    GOODFELLOW, PJ
    DONISKELLER, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) : 1579 - 1583
  • [24] Detection of the mutation of ret proto-oncogene in a pedigree with multiple endocrine neoplasia 2a
    Chen, H.
    Luo, J.-W.
    Zhang, Z.-J.
    JOURNAL OF HYPERTENSION, 2007, 25 : S129 - S130
  • [25] Ligand stimulation of a Ret chimeric receptor carrying the activating mutation responsible for the multiple endocrine neoplasia type 2B
    Rizzo, C
    Califano, D
    ColucciDAmato, GL
    DeVita, G
    DAlessio, A
    Dathan, NA
    Fusco, A
    Monaco, C
    Santelli, G
    Vecchio, G
    Santoro, M
    deFranciscis, V
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) : 29497 - 29501
  • [26] Detection of RET protooncogene mutation in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2)
    Komminoth, P
    MulettaFeurer, S
    Soltermann, A
    Gemsenjager, E
    Burgi, H
    Staub, JJ
    Schonle, E
    Fried, M
    Vetter, W
    Spinas, GA
    Heitz, PU
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 126 (31-32) : 1329 - 1338
  • [27] A mutation in the RET proto-oncogene in Hirschsprung's disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B
    Cosma, MP
    Panariello, L
    Quadro, L
    Dathan, NA
    Fattoruso, O
    Colantuoni, V
    BIOCHEMICAL JOURNAL, 1996, 314 : 397 - 400
  • [28] Prenatal molecular diagnosis of RET proto-oncogene mutation in multiple endocrine neoplasia type 2A
    Huang, SM
    Tao, BL
    Tzeng, CC
    Liu, HT
    Wang, WP
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1997, 96 (07) : 542 - 544
  • [29] Mutation of RET gene causes multiple endocrine neoplasia type 2B in an Adolescent: report of one case and literature review
    Zhang, Lidan
    Guo, Yan
    Ye, Lei
    Dong, Zhiya
    Lu, Wenli
    Wang, Wei
    Xiao, Yuan
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 615 - 615
  • [30] The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis
    Eng, C
    Clayton, D
    Schuffenecker, I
    Lenoir, G
    Cote, G
    Gagel, RF
    vanAmstel, HKP
    Lips, CJM
    Nishisho, I
    Takai, SI
    Marsh, DJ
    Robinson, BG
    FrankRaue, K
    Raue, F
    Xue, FY
    Noll, WW
    Romei, C
    Pacini, F
    Fink, M
    Niederle, B
    Zedenius, J
    Nordenskjold, M
    Komminoth, P
    Hendy, GN
    Gharib, H
    Thibodeau, SN
    Lacroix, A
    Frilling, A
    Ponder, BAJ
    Mulligan, LM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19): : 1575 - 1579